Professor Nigel Temperton

Chair in Molecular Virology


Curriculum vitae



01634 202957


Medway School of Pharmacy

University of Kent

Medway School of Pharmacy,
Anson Building,
Central Avenue,
Chatham Maritime,
Kent, ME4 4TB
United Kingdom



Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes.


Journal article


C. Genova, A. Sampson, S. Scott, D. Cantoni, M. Neto, E. Bentley, G. Mattiuzzo, E. Wright, Mariliza Derveni, B. Auld, Billy Ferrara, Dale Harrison, Mohamed Said, Arwa Z. Selim, Elinor P. Thompson, C. Thompson, G. Carnell, Nigel J. Temperton
Bio-protocol, 2021

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Genova, C., Sampson, A., Scott, S., Cantoni, D., Neto, M., Bentley, E., … Temperton, N. J. (2021). Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes. Bio-Protocol.


Chicago/Turabian   Click to copy
Genova, C., A. Sampson, S. Scott, D. Cantoni, M. Neto, E. Bentley, G. Mattiuzzo, et al. “Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes.” Bio-protocol (2021).


MLA   Click to copy
Genova, C., et al. “Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes.” Bio-Protocol, 2021.


BibTeX   Click to copy

@article{c2021a,
  title = {Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes.},
  year = {2021},
  journal = {Bio-protocol},
  author = {Genova, C. and Sampson, A. and Scott, S. and Cantoni, D. and Neto, M. and Bentley, E. and Mattiuzzo, G. and Wright, E. and Derveni, Mariliza and Auld, B. and Ferrara, Billy and Harrison, Dale and Said, Mohamed and Selim, Arwa Z. and Thompson, Elinor P. and Thompson, C. and Carnell, G. and Temperton, Nigel J.}
}

Abstract

This protocol details a rapid and reliable method for the production and titration of high-titre viral pseudotype particles with the SARS-CoV-2 spike protein (and D614G or other variants of concern, VOC) on a lentiviral vector core, and use for neutralisation assays in target cells expressing angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). It additionally provides detailed instructions on substituting in new spike variants via gene cloning, lyophilisation and storage/shipping considerations for wide deployment potential. Results obtained with this protocol show that SARS-CoV-2 pseudotypes can be produced at equivalent titres to SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV) pseudotypes, neutralised by human convalescent plasma and monoclonal antibodies, and stored at a range of laboratory temperatures and lyophilised for distribution and subsequent application.



Tools
Translate to